Mary Ortner, PhD, MBA, accepts the position of president and CEO. She was previously SVP, business development and corporate alliances, at BioXcel Corporation. By jordan|2022-03-22T20:42:33+00:00February 1, 2022|2013-announcements|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail About the Author: jordan Related Posts Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico. Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico. Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology. Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology. Biophagy signs an option with STC.UNM to license and develop autophagy-related technologies and molecules created at the University of New Mexico Biophagy signs an option with STC.UNM to license and develop autophagy-related technologies and molecules created at the University of New Mexico Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.
Leave A Comment